286 related articles for article (PubMed ID: 19269691)
1. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
2. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
3. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
Keers R; Uher R; Gupta B; Rietschel M; Schulze TG; Hauser J; Skibinska M; Henigsberg N; Kalember P; Maier W; Zobel A; Mors O; Kristensen AS; Kozel D; Giovannini C; Mendlewicz J; Kumar S; McGuffin P; Farmer AE; Aitchison KJ
J Affect Disord; 2010 Dec; 127(1-3):337-42. PubMed ID: 20609482
[TBL] [Abstract][Full Text] [Related]
4. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
5. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
Bär KJ; Schuhmacher A; Höfels S; Schulz S; Voss A; Yeragani VK; Maier W; Zobel A
J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
7. Changes in body weight during pharmacological treatment of depression.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Keers R; Gray JM; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Szczepankiewicz A; Kalember P; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
Int J Neuropsychopharmacol; 2011 Apr; 14(3):367-75. PubMed ID: 20716398
[TBL] [Abstract][Full Text] [Related]
8. Placebo response and antidepressant response.
Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
[TBL] [Abstract][Full Text] [Related]
10. Variation in GNB3 predicts response and adverse reactions to antidepressants.
Keers R; Bonvicini C; Scassellati C; Uher R; Placentino A; Giovannini C; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Hauser J; Souery D; Mendlewicz J; Schmäl C; Zobel A; Larsen ER; Szczepankiewicz A; Kovacic Z; Elkin A; Craig I; McGuffin P; Farmer AE; Aitchison KJ; Gennarelli M
J Psychopharmacol; 2011 Jul; 25(7):867-74. PubMed ID: 20826553
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of drug-metabolising enzymes in antidepressant side effects.
Hodgson K; Tansey KE; Uher R; Dernovšek MZ; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Craig IW; Aitchison KJ; Farmer AE; Dobson RJ; McGuffin P
Psychopharmacology (Berl); 2015 Jul; 232(14):2609-17. PubMed ID: 25761838
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression.
Marraccini RL; Reynolds CF; Houck PR; Miller MD; Frank E; Perel JM; Cornes C; Mazumdar S; Kupfer DJ
Int J Geriatr Psychiatry; 1999 Dec; 14(12):1014-8. PubMed ID: 10607968
[TBL] [Abstract][Full Text] [Related]
13. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
[TBL] [Abstract][Full Text] [Related]
14. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
Janssen J; Hulshoff Pol HE; Schnack HG; Kok RM; Lampe IK; de Leeuw FE; Kahn RS; Heeren TJ
Int J Geriatr Psychiatry; 2007 May; 22(5):468-74. PubMed ID: 17357181
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
16. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
18. History of suicide attempts among patients with depression in the GENDEP project.
Perroud N; Uher R; Hauser J; Rietschel M; Henigsberg N; Placentino A; Kozel D; Maier W; Mors O; Souery D; Dmitrzak-Weglarz M; Jorgensen L; Kovacic Z; Giovannini C; Mendlewicz J; Zobel A; Strohmaier J; McGuffin P; Aitchison KJ; Farmer A
J Affect Disord; 2010 Jun; 123(1-3):131-7. PubMed ID: 19772940
[TBL] [Abstract][Full Text] [Related]
19. Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.
Cattaneo A; Ferrari C; Uher R; Bocchio-Chiavetto L; Riva MA; ; Pariante CM
Int J Neuropsychopharmacol; 2016 Oct; 19(10):. PubMed ID: 27207917
[TBL] [Abstract][Full Text] [Related]
20. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
